^
Association details:
Biomarker:CYB5A rs1790834
Cancer:Prostate Cancer
Drug:abiraterone acetate (CYP17A1 inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Title:

Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients

Published date:
06/04/2020
Excerpt:
The SNP rs1790834 on CYB5A showed significant association with PSA response in CRPC patients treated with AA/P (P < 0.05)…
DOI:
10.2147/PGPM.S245086